Introduction
Ovarian hyperstimulation syndrome (OHSS) is a potential complication of ovarian stimulation in in-vitro fertilization treatments (Schenker and Weinstein, 1978; Delvigne and Rozenberg, 2003; Chen et al., 2008a) . A critical condition may develop with massive ascites, pleural effusion, hemoconcentration, oliguria and thrombosis. The underlying cause is an increase in the vascular permeability of enlarged ovaries and other mesothelial surfaces with acute fluid shift out of the intravascular space (Alvarez et al., 2007a; Villasante et al., 2007) . Angiogenic cytokines including vascular endothelial growth factor (VEGF), interleukin (IL)-6, IL-8, basic fibroblast growth factor (bFGF), tumor necrotic factor-a (TNF-a), etc . produced by multiple corpora luteae may be involved in OHSS (Elchalal and Schenker, 1997; Stanek et al., 2007; Stocco et al., 2007; Varnagy et al., 2009) . VEGF is thought to be an attributing factor (McClure et al., 1994; Levin et al., 1998; Manau et al., 2007) . However, the effects of remaining angiogenic cytokines on OHSS are vague.
The development of OHSS following ovarian stimulation with gonadotropins is mainly associated with the administration of human chorionic gonadotrophin (hCG), as the syndrome rarely develops if it is withheld (Nargund et al., 2007; van de Lagemaat et al., 2009; Vardhana et al., 2009 ). In addition, OHSS becomes more severe after pregnancy occurs. It had been shown that expressions of VEGF mRNA and secretion of VEGF protein were positively regulated by hCG in granulosa-lutein cells (Neulen et al., 1995; Chen et al., 2008b) . However, the signal pathway of hCG-mediating VEGF secretion is still unclear (Stocco et al., 2007) .
Lysophophatidic acid (LPA) had been detected to exist at considerable amounts in follicular fluid of pre-ovulatory follicles (Tokumura et al., 1999) . In the previous study, we found that LPA mediated IL-8 and IL-6 expressions of granulosa-lutein cells through LPA receptors, mitogen activating protein kinase (MAPK) and nuclear factor (NF)-kB dependent pathways. LPA-induced IL-8 and IL-6 increased angiogenesis and permeability of endothelial monolayer (Chen et al., 2008b) . However, the signals of these vasoactive cytokines in endothelial cells involved in OHSS remain elusive.
Conservative treatments with fluid, electrolyte and albumin supplements or paracentesis are primarily used for OHSS (Delvigne and Rozenberg, 2003; Chen et al., 2008a) . However, these methods may be not effective for a life-threatening OHSS. The change of endothelial permeability may be determined by inter-endothelial junctions (Chiba et al., 2006; Petreaca et al., 2007; Villasante et al., 2008; Dejana et al., 2008; Rodewald et al., 2009) . A better understanding of the pathophysiological and signal mechanisms would be helpful for optimal treatments. Dopamine, a catecholamine neurotransmitter, is synthesized from the amino acid tyrosine. It is found in the central nervous system, in the periphery at the sympathetic nerve endings, in chromaffin tissues and in mucosal tissues (Chakroborty et al., 2009) . Dopamine is present in measurable quantities (1 mM) at nerve synapses which are often adjacent to blood vessels in normal adult tissues (Basu et al., 2001) . It has been demonstrated that dopamine receptors are present on endothelial cells and dopamine might exert anti-tumor effect by inhibiting tumor angiogenesis (Chakroborty et al., 2009) . The effects of dopamine on the follicular fluid-induced angiogenesis deserve further investigation.
In this study, we explore the effects of angiogenic cytokines of follicular fluid and ascites from patients with risk of OHSS on the endothelial permeability. We examine the molecular signal pathways in granulosa-lutein cells and endothelial cells possibly involved in OHSS. Furthermore, we investigate the potential chemotherapeutics that target these signals, for reducing endothelial permeability.
Materials and Methods

Reagents
Human VEGF, IL-1a, IL-1b, IL-6, IL-8, TNF-a, bFGF and platelet-derived growth factor (PDGF) neutralizing antibodies were obtained from R&D Systems (Minneapolis, MN, USA). Chemical inhibitors of signal mediators including MDL12, H89, U73122, LY294002, SB203580, PD98059, SP600125, staurosporine, CBO-P11, repertaxin, C3 exozyme and Y-27632 were purchased from Sigma-Aldrich (Saint Louis, MO, USA). Antibodies of Sp1, cAMP response element binding protein (CREB), CXCR1, CXCR2, Rho, VE-cadherin and occludin were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies of phospho-Sp1 (T453) and phospho-VE-cadherin (Y731) were from Abcam Biotechnology (Cambridge, MA, USA). Antibodies of phospho-CREB (Ser133), and phospho-VEGFR-2 (Tyr951) were obtained from R&D Systems.
Follicular fluid and ascites
This study was approved by the ethics committee of the National Taiwan University Hospital. Follicular fluid was obtained from patients (n ¼ 22) undergoing controlled ovarian stimulation and transvaginal aspiration of follicles for in-vitro fertilization with more than 20 follicles. To obtain the follicular fluid and avoid contamination from blood and flush medium during oocyte retrieval, only the follicular fluid from the first retrieved follicle (mean diameter of 18 -20 mm) from bilateral ovaries was collected. The presence or absence of blood contamination was determined by visual inspection, and samples with blood stain were discarded. Meticulous care was taken to include only uncontaminated samples. Ascites was obtained from patients (n ¼ 8) undergoing paracentesis due to severe OHSS. The obtained fluid was centrifuged at 350g for 5 min to remove cells and frozen at 2708C for subsequent assays.
Granulosa-lutein cell culture
The granulosa-lutein cells were collected from follicular aspirates of patients with more than 20 follicles. Follicular fluid from all follicles was collected and then centrifuged at 350g for 5 min. The cells were resuspended in 10 ml of hepes-buffered human tubal fluid (HTF) medium. The cell suspensions were layered onto 10 ml Ficoll (Sigma-Aldrich). After centrifugation at 450g for 15 min, the interphase cells were collected. The granulosa-lutein cells were treated with 80 IU/ml hyaluronidase in 1 ml HTF for 10 min for dispersion of cells. The cells were washed and suspended in RPMI containing 10% fetal bovine serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin and 0.25 mg/ml amphotericin B. The granulosalutein cells were seeded in a flask. On the second day, the cells were washed to remove remaining red blood cells, as these did not adhere to the plastic surface. The cells were then incubated at 378C in a humidified atmosphere with 5% CO 2 in air. Three days after collection, the cultured granulosa-lutein cells were used for experiments.
Enzyme immunoassay
Levels of free VEGF-A, IL-1a, IL-1b, IL-6, IL-8, TNF-a, bFGF or PDGF of follicular fluid, ascites and supernatant of granulosa-lutein cell culture were determined using enzyme immunoassay (EIA) kits (R&D Systems). The intra-and inter-assay coefficients of variation for VEGF-A were 5.1 and 6.2%, respectively; for IL-1a were 1.4 and 4.3%, respectively; for IL-1b were 8.5 and 8.4%, respectively; for IL-6 were 2.0 and 3.8%, respectively; for IL-8 were 6.5 and 6.1%, respectively; for TNF-a were 8.6 and 7.0%, respectively; for bFGF were 8.7 and 13.4%, respectively; and for PDGF were 8.7 and 12.0%, respectively.
Human umbilical vein endothelial cells permeability assay
Human umbilical vein endothelial cells (HUVEC) were isolated from fetal umbilical cord after Cesarean section and cultured in endothelial cell culture medium (Sigma-Aldrich) with 10% fetal bovine serum. Horseradish peroxidase diffusion through HUVEC monolayer was measured as previously described (Essler et al., 1999) , with some modifications. HUVEC were cultured in trans-well chambers (0.4 mm pore-size polycarbonate filters; Costar Corp., Cambridge, MA, USA). After reaching confluence, the medium was replaced with the indicated conditions (0.3 ml in the upper chamber and 1 ml in the lower chamber). Horseradish peroxidase molecules (Type VI-A, 44 kDa; Sigma-Aldrich) at a concentration of 0.126 mM were added to the upper compartment. After incubation for 1 h, the medium in the lower compartment was collected and assayed for enzymatic activity using a photometric guaiacol substrate assay (Sigma-Aldrich). The reaction was allowed to proceed for 15 min at room temperature, and absorbance was measured at 450 nm.
RNA interference
Small interfering RNA duplexes (siRNA) of hCG/LH receptor gene (SC-40105) were purchased from Santa Cruz Biotechnology. Negative control siRNAs (Invitrogen Corporation, Carlsbad, CA, USA) with sequences that did not target any gene product was used for control. Lyophilized siRNA duplex was resuspended in the RNase-free water to form a 10 mM solution in a 10 mM Tris -HCl, pH 8.0, 20 mM NaCl, 1 mM EDTA buffered solution. The siRNA was incubated for 15 min at room temperature to allow complex formation between siRNA and TransFast TM Transfection Reagent (Promega, Southampton, UK). Granulosa-lutein cells (2.5 Â 10 5 /ml in 6-cm dish) were transfected with siRNA in serum-free Opti-MEM (Invitrogen Corporation, Carlsbad, CA, USA) at a concentration of 25 nM by incubation for 1 h at 378C. The cells were then changed for culture medium and incubated for 24 h at 378C prior to experiments.
Western blotting
The granulosa-lutein cells were lysed in a lysis buffer. The cell lysates were centrifuged at 30 000g for 25 min at 48C. The protein concentration was measured with a Bio-Rad protein assay (Hercules, CA, USA). A 50-mg protein sample was separated by 10% of sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and then transferred onto the polyvinylidene difluoride membrane (Sigma-Aldrich). The membranes were blocked with 5% fat-free milk for non-phosphorylated form of protein or with 5% BSA for phosphorylated form for 30 min, and then immunoblotted with various primary antibodies (0.2 mg/ml) for 1 h at room temperature. The bound antibodies on the membrane were detected using appropriate peroxidase-coupled secondary antibodies (0.08 mg/ml) for 30 min. The signal was detected by X-ray film (Kodak, Windsor, CO, USA) with an enhanced chemiluminescent detection system (ECL; Boehringer Mannheim, Indianapolis, IN, USA).
Double-stranded oligodeoxynucleotides decoys
The procedures of oligodeoxynucleotides decoy assay were performed based on previous description (Wu et al., 2007) . Synthetic doublestranded oligodeoxynucleotides were used as 'decoy' cis elements to block the binding of nuclear factors to promoter regions of the targeted genes, thus inhibiting gene transactivation. The sequences of the phosphorothioate oligodeoxynucleotides for various decoys were 5 0 -TGT CTG ACT CAT GTC-3 0 for activator protein 1 (AP-1); 5 0 -TAC AGA ACA TGT CTA AGC ATG CTG GGG-3 0 for p53; 5'-ATT CCG GGG GCG GGG GCA TG-3 0 for Sp1; and 5 0 -TGA CGT CAT GAC GTC ATG ACG TCA-3 0 for cAMP response element (CRE). For transfection of granulosa-lutein cells, the AP-1, p53, Sp1 or CRE decoys at the concentration of 1 mM were mixed with the Transfast transfection reagent (Promega) for 15 min and then incubated with the cells in a serum-free medium. The specificity of the above decoys was verified with control scrambled decoys (Chen et al., 2008b) .
GTP-Rho pull-down assay
Active Rho was determined by GTP-Rho pull-down assay as described previously (Shimizu et al., 2007) , with some modifications. Briefly, HUVEC that treated with different conditions were lysed with cold lysis buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA, 5 mM MgCl 2 , 10% glycerol, 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM dithiothreitol, 50 mg/ml phenylmethylsulfonyl fluoride, 10 mg/ml each of leupeptin and pepstatin and 1% Nonidet P-40). The cell lysates were centrifuged, 30 000g, at 48C for 20 min and the supernatants were collected. A half volume of supernatants were incubated with 20 mg of glutathione Stransferase/Rho-binding domain fusion protein conjugated with glutathione beads (Thermo Fisher Scientific Inc., Rockford, IL, USA) for 2 h at 48C. The beads bound with Rho-GTP were washed twice with lysis buffer, and were then boiled in SDS-PAGE loading buffer. Rho-GTP was detected by western blotting. Precipitated proteins were analyzed by 12% SDS-PAGE and immunoblotting. Total Rho in the other half volume of supernatants was detected as input control.
Actin stain and fluorescence microscopy
Stain of filamentous actin (F-actin) was performed based on previous description (Eiselein et al., 2007) . HUVEC on collagen-coated trans-well membranes were washed with phosphate-buffered saline (PBS) and then fixed with 4% paraformaldehyde for 20 min. They were then washed three times in PBS, and permeabilized with 0.1% Triton-X-100. Fluorescence isothiocyanate-conjugated phalloidin (Invitrogen), diluted in PBS (2 U/ml), was then applied to the specimens in the dark for 1 h. The specimens were mounted with 10% glycerol. The images were viewed using a fluorescence microscope (Nikon, Tokyo, Japan).
HUVEC migration assay
A total of 2 Â 10 4 HUVEC in 200 ml of culture medium were added to the upper chamber of the 24-well Millicell inserts (8 mm pore; Millipore Corporate, Bedford, MA, USA), with 500 ml of culture medium added to the lower chamber. After 1 h for cell attachment, the medium was changed to serum-free medium in the upper chamber and to the indicated conditioned medium in the lower chamber. Following incubation for 6 h to allow endothelial cells to migrate across the membrane, the inserts were then disassembled. The upper wells were fixed with 1% formaldehyde solution. The cells remaining on the upper surface of the filter were removed using a rubber scraper. Cells migrating across the filter onto the lower surface were counted under a microscope (Â20).
HUVEC capillary tube formation assay
) in the medium of indicated conditions were plated on a growth factor-reduced Matrigel coated 24-well plates. Following incubation for 6 h to allow the tube formation, the wells were observed under a phasecontrast microscope (Â20). The tube formation was defined as the formation of capillary-like structure with a complete ring composed by endothelial cells (Tamilarasan et al., 2006) . To quantify tube formation, six random fields were imaged and the mean value was calculated.
Statistics
In this study, each experiment was repeated at least three times on different occasions. Data were presented as mean + standard deviation (SD). The data were examined with one-way analysis of variance, followed by Tukey test for multiple comparisons. Significance level was set as P , 0.05 by two-tailed test. SAS software version 8.01 (SAS Institute Inc., Cary, NC, USA) was used for calculation.
Results
Angiogenic factors of follicular fluid and ascites inducing endothelial permeability
Using EIA, we measured the concentrations of various angiogenic cytokines in the follicular fluid and ascites (Table I ). The levels of Signal mechanisms of OHSS these cytokines in the follicular fluid were comparable to those of ascites. Using HUVEC permeability assay, with pre-incubation of neutralizing antibodies of various cytokines, the follicular fluid-induced permeability was reduced, to different degrees (Fig. 1A, n ¼ 22) . When the endothelial permeability induced by follicular fluid was defined as 100%, the relative permeability was significantly reduced to 43.6 + 10.7% by VEGF antibody and to 33.6 + 25.4% by IL-8 antibody. The differences were not significant when follicular fluid was pretreated with antibodies of IL-6, bFGF, TNF-a, IL-1a, IL-1b or PDGF. The comparable results were found in the experiments of ascites (Fig. 1B, n ¼ 8) . The relative permeability was significantly diminished to 45.6 + 19.3% by VEGF antibody and to 53.8 + 14.6% by IL-8 antibody.
We further performed the HUVEC permeability assay of the blank (controlled) medium and co-incubation studies. We found that follicular fluid significantly enhanced endothelial permeability, compared with the controlled medium. By co-incubation of VEGF and IL-8 neutralizing antibodies with follicular fluid, the relative permeability was remarkably decreased to 9.8 + 6.0% for the follicular fluid-induced permeability. The relative permeability was not significantly different between the blank medium group and the co-incubation group (Fig. 1C, n ¼ 22) . The comparable results were found in the experiments of ascites. Ascites significantly led to endothelial hyperpermeability, compared with the controlled medium. By co-incubation of VEGF and IL-8 antibodies with ascites, the relative permeability was remarkably decreased to 12.8 + 7.4% for the ascites-induced relative permeability. The relative permeability was not significantly different between the blank medium group and the co-incubation group (Fig. 1D, n ¼ 8) .
Signal transduction pathways involved in hCG-inducing VEGF secretions in granulosa-lutein cells effectively inhibited its expression ( Fig. 2A, left panel) . We found that hCG induced VEGF secretion of granulosa-lutein cells via LH/hCG receptor, as evidence of a significant decrease of VEGF secretion by treatment with LH/hCG receptor siRNA ( Fig. 2A, right panel) . We investigated the signal mechanism using chemical inhibitors of adenylate cyclase (MDL12) and protein kinase A (PKA) (H89) and phospholipase C (PLC) (U73122). The data showed that MDL12, H89 and U73122 significantly inhibited hCG-mediated VEGF secretions of granulosa-lutein cells (Fig. 2B) . The signal mediators involved in hCG-enhanced VEGF secretion were further explored using inhibitors of PI3K/Akt (LY294002), MAPK/p38 (SB203580), MAPK/ERK (PD98059), JNK (SP600125) and PKC (staurosporine). The results revealed that staurosporine significantly diminished hCG-enhanced VEGF secretion (Fig. 2C) .
We further applied the AP-1, p53, Sp1 and CRE decoy oligodeoxynucleotides strategy to ascertain the transcription factors involved. We found that Sp1 and CRE decoys, but not AP-1 or p53 decoys, significantly inhibited hCG-induced VEGF secretion in granulosa-lutein cells (Fig. 2D) . Using western blotting and densitometry, we explored signal cascades of hCG inducing Sp1 and CREB activation. We found that hCG induced phosphorylation of Sp1. The phosphorylation was significantly decreased by pretreatment with PLC inhibitor (U73122) and PKC inhibitor (staurosporine) (Fig. 2E) . We observed that hCG induced phosphorylation of CREB. The phosphorylation was significantly diminished by adenylate cyclase inhibitor (MDL 12) and PKA inhibitor (H89) (Fig. 2F) .
These results indicate that via LH/hCG receptor, hCG induces VEGF secretion of granulose-lutein cells through PLC/PKC/Sp1 and adenylate cyclase/PKA/CREB signal pathways. (A) LH/hCG receptor critically involved in hCG-mediated VEGF secretion in granulosa-lutein cells. Left panel: the presence of LH/hCG receptor (R) in cultured granulosa-lutein cells and the effect of siRNA on the inhibition of LH/hCG receptor expression, examined by western blotting. Right panel: the cells were pretreated with LH/hCG R siRNA prior to hCG (1 IU/ml) treatment. After 48 h, VEGF secretion was detected by EIA. *P , 0.05; n ¼ 5. (B) The granulosa-lutein cells were pretreated with indicated chemical inhibitors of MDL12 (20 mM), H89 (25 mM) and U73122 (1 mM) for 1 h prior to hCG treatment. Data are compared between the hCG-treated-only group and different inhibitor groups. *P , 0.05; n ¼ 5. (C) The granulosa-lutein cells were pretreated with LY294002 (50 mg/ml), SB203580 (5 mg/ml), PD98 059 (50 mg/ml), SP600125 (10 mM) and staurosporine (0.25 mM) for 1 h prior to hCG stimulation. *P , 0.05; n ¼ 5. (D) The granulosa-lutein cells were transfected with indicated decoy oligodeoxynucleotides (1 mM) for 24 h, and then treated with hCG. *P , 0.05; n ¼ 5. (E) HCG induced Sp1 phosphorylation through PLC/PKC signaling, examined by western blotting. Data were measured as relative density (RD) of p-Sp1/Sp1. The p-Sp1/Sp1 of the first lane control was defined as 1. Data are compared between the hCG-treated-only group and different inhibitor groups. *P , 0.05; n ¼ 3. (F) HCG induced CREB phosphorylation through adenylate cyclase/PKA signaling. *P , 0.05; n ¼ 3.
Signaling pathways of VEGF and IL-8 of follicular fluid inducing endothelial permeability
Using western blotting and densitometry, we found that follicular fluid strongly induced VEGFR-2 phosphorylation of endothelial cells. The phosphorylation was significantly reduced by pretreatment with IL-8 antibody or VEGF antibody (Fig. 3A) . We further verified that follicular fluid induced phosphorylations of CXCR1/2 of endothelial cells. The phosphorylations were decreased by pretreatment of IL-8 antibody (Fig. 3B) . The inhibitor of CXCR1/2 (repertaxin) diminished IL8-induced VEGFR-2 phosphorylation (Fig. 3C) . These data suggest that through CXCR1/2, IL-8 of follicular fluid transactivates VEGFR-2 of endothelial cells.
Using Rho-GTP pull-down assays, we further demonstrated that follicular fluid strongly induced Rho-GTP expression of endothelial cells. The follicular fluid-induced Rho-GTP expression was significantly reduced when the follicular fluid was pre-incubated with either IL-8 antibody or VEGF antibody. In addition, the follicular fluid-induced Rho-GTP expression was significantly inhibited when the endothelial cells were pretreated with the inhibitor of VEGFR-2 (CBO-P11) (Fig. 3D) .
Using western blotting, we verified that follicular fluid induced phosphorylations of VE-cadherin and occludin of endothelial cells. The follicular fluid-induced phosphorylations of VE-cadherin and occludin of endothelial cells were significantly reduced when the follicular fluid was pre-incubated with either IL-8 antibody or VEGF antibody. In addition, the phosphorylations were significantly inhibited by inhibitors of Rho (C3 exozyme) and ROCK (Y-27632) (Fig. 3E and F) . With HUVEC permeability assay, we further demonstrated that follicular fluid-induced endothelial permeability was significantly reduced by repertaxin, CBO-P11, C3 exozyme and Y-27623 (Fig. 3G) .
Using actin stain, we found that follicular fluid remarkably induced actin polymerization and increased paracellular gap formation of endothelial cells (Fig. 4B ), in comparison with the morphology of endothelial cells in culture medium (Fig. 4A) . The follicular fluid-induced polymerization of actin was partially inhibited when follicular fluid was pre-incubated with either VEGF antibody (Fig. 4C) or IL-8 antibody (Fig. 4D) . The actin polymerization was considerably inhibited by co-incubation with both VEGF antibody and IL-8 antibody (Fig. 4E) . The follicular fluid-induced actin polymerization was also extensively diminished when endothelial cells were pretreated with inhibitors of VEGFR-2 (CBO-P11), Rho (C3 exozyme) and ROCK (Y-27632) (Fig. 4F-H) .
Effects of dopamine on the follicular fluid-induced endothelial permeability and other steps of angiogenesis
Using HUVEC permeability assay, we found that the follicular fluid-induced endothelial permeability was diminished by dopamine treatment in a dose-dependent mode. At 2 mM, dopamine significantly reduced the relative permeability to 50 + 3.8% when the follicular fluid treatment control was defined as 100% (Fig. 5A) . With western blotting, we found that dopamine inhibited follicular fluid-induced phosphorylation of VEGFR-2 of endothelial cells (Fig. 5B) . We further observed that dopamine reduced follicular fluid-induced phosphorylations of VE-cadherin and occludin of endothelial cells (Fig. 5C and D) .
We explored the effects of dopamine on other steps of angiogenesis. We found that at the lower doses (0.5, 2 mM), dopamine did not inhibit follicular fluid-induced migration and capillary tube formation of endothelial cells. But it significantly blocked these actions at the higher dose (10 mM) (Fig. 5E and F) .
The representation of possible signal pathways of VEGF and IL-8 in granulosa-lutein cells and endothelial cells contributing to the mechanisms of OHSS and dopamine targeting the common VEGFR-2 signaling is schematically summarized in Fig. 6 .
Discussion
Compared with the controlled blank medium, both follicular fluid and ascites significantly enhanced endothelial permeability. The results of individual neutralizing antibody and co-incubation studies suggest that among various angiogenic cytokines of follicular fluid and ascites, VEGF and IL-8 may play major roles in inducing endothelial hyperpermeability of OHSS. We further delineate the signal pathways of VEGF and IL-8 in granulosa-lutein cells and endothelial cells possibly involved in OHSS. We find that hCG induces VEGF secretion of granulosa-lutein cells through Sp1 and CREB dependent pathways. Using neutralizing antibodies, we find that both VEGF and IL-8 contribute to follicular fluid-induced VEGFR-2 phosphorylation, activation of Rho, actin polymerization and phosphorylations of VE-cadherin and occludin of endothelial cells. IL-8 of follicular fluid acts on CXCR1/2 of HUVEC and leads to VEGFR-2 transactivation. The possible mechanisms may involve IL-8-inducing VEGF release by HUVEC or IL-8-transactivating VEGFR-2 directly, which merits further investigation.
We use the strategy of chemical inhibitors for clarification of the signal cascade of both VEGF and IL-8 of follicular fluid in inducing endothelial permeability. With inhibitors of VEGFR-2, Rho and Rock, the results suggest that through a common VEGFR-2 signal, both VEGF and IL-8 of follicular fluid induce endothelial permeability via activation of Rho/Rock resulting in polymerization of actin and phosphorylations of VE-cadherin and occludin with opening of adherens and tight junctions. The step-by-step strategies using both neutralizing antibodies and chemical inhibitors facilitate delineation of the signal pathway. van den Driesche et al. (2008) found that hCG could augment hypoxia inducing factor-1a (HIF-1a) and VEGF expressions under hypoxic conditions. Recently, Rodewald et al. (2007 Rodewald et al. ( , 2009 ) suggest that hCG may increase endothelial permeability by up-regulating VEGF in granulosa-lutein cells which causes reduction in endothelial specific tight junction protein, claudin 5, expression. The clarification of pathophysiological mechanisms would be helpful to find therapeutic agents for the targeted treatment of OHSS.
To reduce the secretion of IL-8 or VEGF from corpora luteae may be an approach to treat OHSS. In our previous study, we found that LPA induced IL-8 secretion of granulosa-lutein cells through NF-kB dependent pathway (Chen et al., 2008b) . Non-steroidal antiinflammatory drugs (NSAIDs) have been recently shown to suppress the activity of NF-kB and the expressions of its related genes (Takada et al., 2004) . Indomethacin had been used as an inhibitor of prostaglandin synthesis to treat OHSS (Schenker and Polishuk, 1976) ; however, the efficacy data remains controversial. Katz et al. (1984) reported that indomethacin effectively treated OHSS. However, Borenstein et al. (1989) found no clinical improvement of ascites in severe OHSS using indomethacin. The effect of indomethacin or various NSAIDs differing in their potency on suppressing NF-kB activity may merit further investigation for OHSS.
We demonstrate that the follicular fluid-or ascites-induced endothelial permeability in vitro is significantly inhibited by pretreatment with both IL-8 and VEGF neutralizing antibodies. In the experiments of recombinant VEGF and endothelial cells, Villasanti et al. (2007) found that anti-human VEGF antibody neutralized VEGF actions of endothelial cells. To use specific antibodies for neutralizing VEGF or IL-8 may be another approach to treat OHSS. Avastin, an antibody of VEGF, is used in clinical cancer therapy with its effect of antiangiogenesis (Ma and Waxman, 2008) . The effect of avastin in the management of severe OHSS may deserve further investigation. On the other hand, angiogenesis is essential for establishment of pregnancy, and VEGF plays an important role (Plaisier et al., 2009 ). Significant potential limitations for a VEGF neutralizing antibody such as risks for implantation and maintenance of pregnancy should be concerned.
On the basis of the results of co-incubation studies, the effects of both VEGF and IL-8 of follicular fluid on endothelial permeability appear additive. These findings suggest that the drug targeting the common VEGFR-2 signals may block the endothelial hyperpermeability induced by both VEGF and IL-8. It has been found that in a mouse cancer model, administration of dopamine blocked VEGF/VEGFR-2-related angiogenesis and endothelial permeability via dopamine receptor (DR)-2 (Basu et al., 2001) . In the present study, we demonstrate that dopamine inhibits follicular fluid-induced VEGFR-2 signaling of endothelial cells and diminishes follicular fluid-induced permeability and other steps of angiogenesis with a dose-dependent manner. Dopamine may block not only VEGF, but also IL-8-induced endothelial permeability through inhibition of common VEGFR-2-mediated pathways. We further find that at the lower dose (2 mM), dopamine inhibited permeability without affecting migration and capillary tube formation of endothelial cells. At the higher dose (10 mM), dopamine hindered all of these steps. Gomez et al. (2006) first investigated the effect of cabergoline, a DR-2 agonist, on OHSS in the rat model. They found that cabergoline reduced vascular permeability without affecting luteal angiogenesis. In the human application, Alvarez et al. (2007a) reported that cabergoline improved ascites by reducing vascular permeability and decreased the incidence of moderate OHSS. However, the incidence of severe OHSS was not significantly decreased. They further reported no difference between the groups with and without cabergoline treatments regarding fertilization, implantation and pregnancy rates of a small number of cases (Alvarez et al., 2007b) . The effect of dopamine or DR-2 agonists in the management of OHSS merits further studies. As both VEGF and IL-8 participate in angiogenesis and implantation of pregnancy (Velez et al., 2008; Chen et al., 2008c) , potential limitations for DR-2 agonists regarding risks for implantation and maintenance of pregnancy should be considered.
Doxycycline, a derivative of tetracycline, has been recently shown to inhibit tumor angiogenesis (Moses et al., 2006) . Fainaru et al. (2008a) found that doxycycline inhibited vascular permeability by targeting the adherens junction of endothelial cells via inducing the VE-cadherin expression and decreasing its phosphorylation. They further reported that doxycycline inhibited peritoneal vascular leakage and ascites accumulation in the hyperstimulated mice (Fainaru et al., 2008b) . The value of doxycycline in preventing or treating human OHSS warrants further studies. (Chen et al., 2008b) . AC: adenylate cyclase.
Signal mechanisms of OHSS
Conclusions
Among various angiogenic cytokines, VEGF and IL-8 secreted from corpora luteae may play major roles in inducing endothelial permeability of OHSS. Delineation of signal pathways of VEGF and IL-8 in granulosa-lutein cells and endothelial cells would facilitate to find possible medicines targeting at the various sites. IL-8 and VEGF increase endothelial permeability through common VEGFR-2-mediated signals. Dopamine inhibited VEGFR-2 and, in a low dose, reduces permeability without affecting migration and capillary tube formation of endothelial cells. Angiogenesis is essential in establishment of pregnancy in that VEGF, placental growth factor, bFGF, IL-8, and angiopoietins, etc. may be involved (Plaisier et al., 2007 (Plaisier et al., , 2009 Velez et al., 2008; Chen et al., 2008c) . To find the targeting medicines for endothelial hyperpermeability in OHSS and to investigate their effects on angiogenesis of pregnancy merits further studies.
